XML 29 R11.htm IDEA: XBRL DOCUMENT v3.20.2

Intangible Assets

12 Months Ended

Jun. 30, 2020

Intangible Assets

Note 5. Intangible Assets

Intangible assets consisted of the following, in thousands: 

		June 30,
		2020				2019
S*Bio Patents—Gross		$	273			$	500
Less: accumulated amortization			(273	)			(239	)
Intangible assets, net		$	—			$	261

Amortization expense of intangible assets for the years ended June 30, 2020, 2019 and 2018 was $34,000, $35,000 and $35,000, respectively. As a result of Helsinn discontinuing the Phase 3 study of pracinostat in AML, we assessed the estimated future cash flows associated with the patents acquired from S*Bio and recorded an impairment charge of $0.2 million to write off the remaining book value of the intangible assets.

X

- Definition

The entire disclosure for all or part of the information related to intangible assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-URI http://asc.fasb.org/topic&trid=2144416

+ Details

Name:	us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration